AllianceBernstein’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

AllianceBernstein’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,680	Closed	-$1.12M	–	3292
2024 Q3	$1.12M	Sell	33,680 -3,660	-10%	-$126K	﹤0.01%	2261
2024 Q2	$1.01M	Buy	37,340 +28,050	+302%	+$553K	﹤0.01%	2294
2024 Q1	$201K	Buy	+9,290	New	+$203K	﹤0.01%	2928

AllianceBernstein's LBPH Position: Q4 2024 in Review

AllianceBernstein sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 33,680 shares — an estimated $1.12M sold.

AllianceBernstein first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $1.12M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

AllianceBernstein reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
AllianceBernstein sold 33,680 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.12M.
AllianceBernstein first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
AllianceBernstein's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.12M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on AllianceBernstein's 13F filing for Q4 2024, filed 12 Feb 2025.